E
Fractyl Health, Inc. GUTS
$1.92 $0.084.35% NASDAQ
Recommendation
Prev Close
$1.84
Volume
7,788,964
Avg Vol (90D)
2,874,308
Market Cap
$252.16M
Dividend & Yield
--
52-Week Range
$0.83 - $3.03
P/E (TTM)
--
EPS (TTM)
-$2.28
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Fractyl Health's (GUTS) "Buy" Rating Reiterated at HC Wainwright
12/3/2025 - MarketBeat
Fractyl Health (GUTS) Study Shows Weight Maintenance After GLP-1 Discontinuation
12/2/2025 - GuruFocus
Fractyl Health's Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs
12/2/2025 - Benzinga
Fractyl Health says procedure can maintain weight loss after stopping GLP-1
12/2/2025 - Seeking Alpha - Healthcare
Fractyl's Revita Procedure Shows 6-Month Post-GLP-1 Weight Stability In REVEAL-1 Study
12/2/2025 - Nasdaq News: Markets
Fractyl Health (GUTS) Achieves Key Milestone with Positive REVEAL-1 Results
12/2/2025 - GuruFocus
Fractyl Health Announces Positive REVEAL-1 Study Results
12/2/2025 - TipRanks Financial Blog
Fractyl Health announces 6-month results from REVEAL-1 Cohort
12/2/2025 - The Fly
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita Procedure
12/2/2025 - Globe Newswire
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
12/1/2025 - GuruFocus
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
12/1/2025 - Globe Newswire
Fractyl Health, Inc. (NASDAQ:GUTS) Given Average Rating of "Moderate Buy" by Brokerages
11/23/2025 - MarketBeat
Canaccord Genuity Group Issues Positive Forecast for Fractyl Health (NASDAQ:GUTS) Stock Price
11/22/2025 - MarketBeat
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
11/22/2025 - Ticker Report
Fractyl Health price target raised by $2 at Canaccord, here's why
11/21/2025 - The Fly
Brokers Set Expectations for Fractyl Health FY2025 Earnings
11/17/2025 - MarketBeat
Fractyl Health (NASDAQ:GUTS) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS
11/14/2025 - MarketBeat
Fractyl Health's Earnings Call Highlights Clinical and Financial Progress
11/14/2025 - TipRanks Financial Blog
Bank of America Securities Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)
11/13/2025 - TipRanks Financial Blog
Fractyl Health Inc (GUTS) Q3 2025 Earnings Call Highlights: Pioneering Weight Loss Solutions ...
11/13/2025 - GuruFocus
Q3 2025 Fractyl Health Inc Earnings Call Transcript
11/13/2025 - GuruFocus
Fractyl Health outlines 2026 Revita pivotal data and PMA submission targets as clinical momentum accelerates
11/13/2025 - SeekingAlpha.com: All News
Fractyl Health, Inc. (GUTS) Q3 2025 Earnings Call Transcript
11/13/2025 - Seeking Alpha: Transcripts
Fractyl Health, Inc. (GUTS) Q3 2025 Earnings Call Transcript
11/13/2025 - SeekingAlpha
Fractyl Health (GUTS) Eyes Transformative Progress in Metabolic Disease
11/12/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$3.00K
EBITDA (TTM)
-$97.67M
EBIT (TTM)
-$98.74M
Net Income (TTM)
-$122.20M
Balance Sheet
Total Assets (Q)
$114.27M
Total Debt (Q)
$62.18M
Total Liabilities (Q)
$117.45M
Book Value Per Share (Q)
-$0.024
Cash Flow
Cash from Operations (TTM)
-$86.03M
Cash from Investing (TTM)
-$787.00K
Cash from Financing (TTM)
$79.81M
Net Change in Cash (TTM)
-$7.01M
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Loading...
Beta
--
7-Day Total Return
37.14%
30-Day Total Return
43.28%
60-Day Total Return
97.45%
90-Day Total Return
-2.54%
Year to Date Total Return
-9.86%
1-Year Total Return
-19.33%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Aug 06, 2025 - $0.83
52-week High
Jun 09, 2025 - $3.03
Valuation
Market Cap
$252.16M - Micro Cap
Enterprise Value
$236.69M
Price/Sales (TTM)
--
Price/Book (Q)
-76.67
Dividends and Shares
Shares Outstanding
64.65
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
fractyl.com
Phone Number
781 902 8800
Address
3 Van de Graaff Drive
Burlington, MA 01803
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed